Fazaclo Alamo Pharmaceuticals - Treatment for Schizophrenia

Fazaclo is an orally disintegrating tablet which dissolves quickly in the mouth (without chewing or the need for water) indicated for the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatment for schizophrenia.

Posted: February 2004

Fazaclo (clozapine) FDA Approval History

View comments

Hide
(web4)